Positive results announced from phase I study of LY-3056480 in sensorineural hearing loss Feb. 7, 2019
Sound Pharmaceuticals enrolls first patient in STOP Ototoxicity phase II study of SPI-1005 Jan. 15, 2019
Sensorion signs letter of intent with Institut Pasteur for hearing loss gene therapy programs Nov. 23, 2018
European clearance for phase II study of SENS-401 for sudden sensorineuronal hearing loss Aug. 20, 2018
RSS